Multidisciplinary collaborative approach to care is required for patients with hematological malignancies in pregnancy.

Vasomotor symptoms are a common problem in women with HR-positive breast cancer receiving anti-cancer therapy.

The application is supported by data from the randomized, double-blind, placebo-controlled phase 3 Vivacity-MG3 study.

HealthDay News — Eight in 10 infants received respiratory syncytial virus (RSV) protection during the 2023 to 2024 season, according to a research letter published online January 8 in JAMA Network ...

Morning-type pattern significantly linked to lower risks for all-cause and cardiovascular disease-specific mortality compared with non-coffee drinking ...

The sNDA is supported by data from the phase 3 ENERGIZE and ENERGIZE-T studies, which evaluated mitapivat vs placebo in patients with NTD and TD alpha- or beta-thalassemia, respectively.

Meaningful reduction in symptoms seen for some taking an extended course outside of the context of an acute infection ...